Abstract
Implantable cardioverter defibrillators (ICD) deliver antitachycardia pacing (ATP) for sustained slow or fast ventricular tachycardia (VT) and shock for V fibrillation (F) or after ATP fails to restore sinus rhythm. Prognostic effects of different appropriate ICD therapies have not fully examined, especially for ATP. This study determined effects of ATP, shocks and the combination on death and heart transplant (HTX) from a single center experience.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
